Complementary medicine in patients with head and neck cancer

IF 1.7 Q2 Medicine

Advances in integrative medicine Pub Date : 2024-12-01 DOI:10.1016/j.aimed.2024.06.002

Benjamin Prokein, Michael Dau, Bernhard Frerich

{"title":"Complementary medicine in patients with head and neck cancer","authors":"Benjamin Prokein, Michael Dau, Bernhard Frerich","doi":"10.1016/j.aimed.2024.06.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Literature shows that up to 40 % of cancer patients use complementary medicine treatments. Most patients do not communicate the usage with their practitioner. There are no studies investigating the prevalence and extent of complementary medicine in head and neck cancer in Germany.</div></div><div><h3>Material and methods</h3><div>Patients undergoing tumor aftercare in our department answered a questionnaire, that investigates subsets of demographic data, health behavior, cancerogenesis and complementary medicine. Data was evaluated in total and relative numbers. Also, Chi-squared test and Phi coefficient were performed to evaluate significant correlations.</div></div><div><h3>Results</h3><div>A total of 102 patients could be included in this study. In the analyzed collective 30 % of patients were interested in complementary medicine. Of those, 71 % have experienced complementary medicine treatments. There was a wide variety of modalities being used. None of the patients has talked with the doctors at tumor aftercare about this usage. Correlation of data showed that gender influenced i.a. health behavior and the usage of complementary medicine before cancer.</div></div><div><h3>Conclusion</h3><div>Investigation revealed that a relevant number of head and neck cancer patients used complementary treatments, but no one talked about it during tumor aftercare. As a “blind spot” in anamnesis and diagnostic, evaluation of complementary medicine before tumor treatment and in aftercare are necessary to improve therapeutic outcome and to prevent potential negative influences like medication interactions.</div></div>","PeriodicalId":7343,"journal":{"name":"Advances in integrative medicine","volume":"11 4","pages":"Pages 254-259"},"PeriodicalIF":1.7000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in integrative medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212958824000600","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

Literature shows that up to 40 % of cancer patients use complementary medicine treatments. Most patients do not communicate the usage with their practitioner. There are no studies investigating the prevalence and extent of complementary medicine in head and neck cancer in Germany.

Material and methods

Patients undergoing tumor aftercare in our department answered a questionnaire, that investigates subsets of demographic data, health behavior, cancerogenesis and complementary medicine. Data was evaluated in total and relative numbers. Also, Chi-squared test and Phi coefficient were performed to evaluate significant correlations.

Results

A total of 102 patients could be included in this study. In the analyzed collective 30 % of patients were interested in complementary medicine. Of those, 71 % have experienced complementary medicine treatments. There was a wide variety of modalities being used. None of the patients has talked with the doctors at tumor aftercare about this usage. Correlation of data showed that gender influenced i.a. health behavior and the usage of complementary medicine before cancer.

Conclusion

Investigation revealed that a relevant number of head and neck cancer patients used complementary treatments, but no one talked about it during tumor aftercare. As a “blind spot” in anamnesis and diagnostic, evaluation of complementary medicine before tumor treatment and in aftercare are necessary to improve therapeutic outcome and to prevent potential negative influences like medication interactions.

查看原文本刊更多论文

头颈癌患者的补充医学

目的文献显示，高达40% %的癌症患者使用补充药物治疗。大多数患者不与他们的医生沟通使用。目前还没有研究调查德国头颈癌补充医学的流行程度和程度。材料与方法在我科接受肿瘤术后护理的患者填写一份调查问卷，调查其人口统计资料、健康行为、肿瘤发生及辅助医学等方面的情况。数据以总数和相对数量进行评估。同时，进行卡方检验和Phi系数检验来评估显著相关性。结果本研究共纳入102例患者。在分析的集体中， %的患者对补充医学感兴趣。其中，71% %经历了补充药物治疗。使用的方式多种多样。没有一个病人在肿瘤治疗后与医生讨论过这种用法。数据的相关性显示，性别影响癌症前的健康行为和补充药物的使用。结论调查显示，有一定数量的头颈部肿瘤患者使用了辅助治疗，但在肿瘤术后护理中没有人谈论辅助治疗。作为记忆和诊断中的一个“盲点”，在肿瘤治疗前和治疗后对补充药物进行评价是改善治疗效果和防止药物相互作用等潜在负面影响的必要条件。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in integrative medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-

CiteScore

3.20

自引率

11.80%

发文量

审稿时长

15 weeks

期刊介绍： Advances in Integrative Medicine (AIMED) is an international peer-reviewed, evidence-based research and review journal that is multi-disciplinary within the fields of Integrative and Complementary Medicine. The journal focuses on rigorous quantitative and qualitative research including systematic reviews, clinical trials and surveys, whilst also welcoming medical hypotheses and clinically-relevant articles and case studies disclosing practical learning tools for the consulting practitioner. By promoting research and practice excellence in the field, and cross collaboration between relevant practitioner groups and associations, the journal aims to advance the practice of IM, identify areas for future research, and improve patient health outcomes. International networking is encouraged through clinical innovation, the establishment of best practice and by providing opportunities for cooperation between organisations and communities.